BiBo Pharma: A Global CDMO Leading in Advanced Biopharmaceutical Manufacturing Technologies
Frost & Sullivan
AUGUST 28, 2024
BiBo Pharma is breaking capacity barriers and reducing antibody drug production costs from the international average of hundreds of dollars to just $10 per gram, offering disruptive solutions to global biopharmaceutical companies. times compared to the current 15,000L (total volume) standard in large-scale biopharmaceutical production.
Let's personalize your content